Kodiak Sciences Inc (KOD)
3.18
+0.16
(+5.30%)
USD |
NASDAQ |
May 31, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Total Assets (Quarterly): 434.76M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 434.76M |
December 31, 2023 | 479.37M |
September 30, 2023 | 547.65M |
June 30, 2023 | 589.66M |
March 31, 2023 | 640.33M |
December 31, 2022 | 666.63M |
September 30, 2022 | 723.99M |
June 30, 2022 | 781.90M |
March 31, 2022 | 850.29M |
December 31, 2021 | 904.22M |
September 30, 2021 | 958.21M |
June 30, 2021 | 997.60M |
March 31, 2021 | 1.033B |
Date | Value |
---|---|
December 31, 2020 | 1.067B |
September 30, 2020 | 480.74M |
June 30, 2020 | 429.37M |
March 31, 2020 | 443.04M |
December 31, 2019 | 358.87M |
September 30, 2019 | 68.92M |
June 30, 2019 | 78.28M |
March 31, 2019 | 87.08M |
December 31, 2018 | 92.19M |
September 30, 2018 | 17.12M |
June 30, 2018 | 21.70M |
December 31, 2017 | 3.244M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
68.92M
Minimum
Sep 2019
1.067B
Maximum
Dec 2020
626.69M
Average
615.00M
Median
Total Assets (Quarterly) Benchmarks
Avalo Therapeutics Inc | 123.73M |
Regeneron Pharmaceuticals Inc | 34.37B |
Ligand Pharmaceuticals Inc | 913.87M |
iBio Inc | 50.15M |
Dare Bioscience Inc | 13.01M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 193.57M |
Shareholders Equity (Quarterly) | 241.19M |